Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study
International Journal of Drug Delivery Technology · 14.11.2026 · 16 (89s)
DOI: 10.25258/ijddt.16.89s.183 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 14.11.2026. Verfasst von Prerna Tiwari und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Smokeless tobacco (SLT) dependence is a pervasive public health burden across South Asia, driving high rates of oral potentially malignant disorders and cardiovascular morbidity. Conventional nicotine replacement and pharmacotherapeutic regimens show modest long-term abstinence rates in SLT chewers. Although classical homoeopathic literature describes several remedies for the constitutional and toxicological effects of tobacco, prospective clinical data evaluating individualized prescriptions remain sparse.
Objectives
To evaluate the clinical effectiveness of individualized homoeopathic medicines in reducing physical nicotine dependence, subjective craving intensity, oral-health-related quality of life impairment, and daily chewing frequency among chronic smokeless tobacco users over a 6-month follow-up period.
Methods
A prospective, single-blind, interventional clinical study was conducted on 100 adult smokeless tobacco users (aged 20–60 years; baseline FTND-ST score ≥ 4) at the outpatient department of Prayas Nasha-Mukti Evam Manochikitsa Kendra, Bhopal, India. Following detailed case-taking and repertorization using the Complete Repertory in CARA software, patients received one of eleven individualized homoeopathic remedies, with interspersed Sacchrum lactis (Rubrum) placebo phases to preserve single-blinding. Prescriptions distributed in descending order of clinical frequency were Arsenicum album (n = 16), Cinchona officinalis [China] (n = 14), Nux vomica (n = 13), Tabacum (n = 11), Ignatia amara (n = 10), Staphysagria (n = 9), Natrum carbonicum (n = 8), Caladium seguinum (n = 7), Erythroxylum coca (n = 5), Phosphorus (n = 4), and Spigelia anthelmia (n = 3). Outcomes were assessed at baseline and 6 months using the Fagerström Test for Nicotine Dependence–Smokeless Tobacco (FTND-ST), Oral Health Impact Profile (OHIP-18), Daily Tobacco Consumption Frequency (sessions/day), and a 0–10 Subjective Craving Visual Analogue Scale.
Results
At the 6-month endpoint, statistically significant reductions were observed across the cohort (N = 100) in FTND-ST scores (6.01 ± 1.99 to 4.38 ± 2.68; mean reduction: 1.63 ± 2.07; Wilcoxon p < 0.001; d = 0.79, r = 0.45), OHIP-18 scores (baseline: 25.14 ± 8.77 vs. 6 months: 20.45 ± 9.99; mean reduction: 4.69 ± 4.17; t = 11.24, p < 0.001; Cohen’s d = 1.12), and subjective craving intensity (7.35 ± 1.84 to 5.89 ± 2.95; mean reduction: 1.46 ± 2.58; Wilcoxon p < 0.001; d = 0.57, r = 0.35). Daily chewing frequency declined from 15.10 ± 5.07 to 14.17 ± 7.09 sessions/day (mean difference: 0.93 ± 4.99; paired t-test p = 0.065; d = 0.19). Subgroup analysis demonstrated distinct clinical profiles: Ignatia amara (Δ = 6.00 ± 4.19, p = 0.001), China (Δ = 5.79 ± 4.58, p = 0.004), Staphysagria (Δ = 5.78 ± 4.66, p = 0.006), and Arsenicum album (Δ = 5.25 ± 3.04, p < 0.001) produced pronounced improvements in oral quality of life and dependence, whereas Tabacum (n = 11) achieved the most marked reduction in daily chewing sessions (Δ = 3.73 ± 4.38, p = 0.008, d = 0.85).
Zitieren
APA
Tiwari, P., Jain, L., Shah, J. N., Choudhary, M., Chinche, A., & Ronia, S. V. (2026). Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study. International Journal of Drug Delivery Technology, 16(89s). https://doi.org/10.25258/ijddt.16.89s.183
Vancouver
Tiwari P, Jain L, Shah JN, Choudhary M, Chinche A, Ronia SV. Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study. International Journal of Drug Delivery Technology. 2026;16(89s). doi:10.25258/ijddt.16.89s.183
BibTeX
@article{Tiwari2026,
author = {Tiwari, Prerna and Jain, Lily and Shah, Jay Nilesh and Choudhary, Mahan and Chinche, Anuj and Ronia, Shipra Verma},
title = {Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {89s},
doi = {10.25258/ijddt.16.89s.183}
}
EUVIMED